CS225599B1 - 2,3,10,11-tetramethoxy-6-/4-tolyl/berbine and its hydrochloride - Google Patents
2,3,10,11-tetramethoxy-6-/4-tolyl/berbine and its hydrochloride Download PDFInfo
- Publication number
- CS225599B1 CS225599B1 CS782682A CS782682A CS225599B1 CS 225599 B1 CS225599 B1 CS 225599B1 CS 782682 A CS782682 A CS 782682A CS 782682 A CS782682 A CS 782682A CS 225599 B1 CS225599 B1 CS 225599B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- hydrochloride
- tolyl
- mixture
- tetramethoxy
- berbine
- Prior art date
Links
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 title claims description 16
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 title claims description 4
- BRLDZKPJJNASGG-KRWDZBQOSA-N alpha-berbine Chemical compound C1=CC=C2CN3CCC4=CC=CC=C4[C@@H]3CC2=C1 BRLDZKPJJNASGG-KRWDZBQOSA-N 0.000 title description 2
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 239000000203 mixture Substances 0.000 description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 8
- 238000002844 melting Methods 0.000 description 8
- 230000008018 melting Effects 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- SWCZIXGXWUQGHG-UHFFFAOYSA-N 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3-(4-methylphenyl)-1,2,3,4-tetrahydroisoquinoline;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CC1C2=CC(OC)=C(OC)C=C2CC(C=2C=CC(C)=CC=2)N1 SWCZIXGXWUQGHG-UHFFFAOYSA-N 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- 239000000155 melt Substances 0.000 description 6
- 238000000354 decomposition reaction Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000012512 characterization method Methods 0.000 description 4
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 4
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- QBJIMTPENIGDOG-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)acetyl chloride Chemical compound COC1=CC=C(CC(Cl)=O)C=C1OC QBJIMTPENIGDOG-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 239000003204 tranquilizing agent Substances 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- UWYZHKAOTLEWKK-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinoline Chemical class C1=CC=C2CNCCC2=C1 UWYZHKAOTLEWKK-UHFFFAOYSA-N 0.000 description 1
- KFDBOENRVXPIPH-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-1-(4-methylphenyl)ethanamine Chemical compound C1=C(OC)C(OC)=CC=C1CC(N)C1=CC=C(C)C=C1 KFDBOENRVXPIPH-UHFFFAOYSA-N 0.000 description 1
- PGZNIWQFERVMKP-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-1-(4-methylphenyl)ethanone Chemical compound C1=C(OC)C(OC)=CC=C1CC(=O)C1=CC=C(C)C=C1 PGZNIWQFERVMKP-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- LTHAWQZXDKSDMD-UHFFFAOYSA-N 6,8,13,13a-tetrahydro-5h-isoquinolino[2,1-b]isoquinoline;hydrochloride Chemical compound Cl.C1=CC=C2CN3CCC4=CC=CC=C4C3CC2=C1 LTHAWQZXDKSDMD-UHFFFAOYSA-N 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 231100000111 LD50 Toxicity 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- -1 N- [2- (3,4-dimethoxyphenyl) -1- (4-tolyl) ethyl] -3,4-dimethoxyphenylacetamide Chemical compound 0.000 description 1
- 238000006929 Pictet-Spengler synthesis reaction Methods 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- IUJDSEJGGMCXSG-UHFFFAOYSA-N Thiopental Chemical compound CCCC(C)C1(CC)C(=O)NC(=S)NC1=O IUJDSEJGGMCXSG-UHFFFAOYSA-N 0.000 description 1
- 239000000538 analytical sample Substances 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000002631 hypothermal effect Effects 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- GFBZBTGJEJNXJN-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)-1-(4-methylphenyl)ethyl]formamide Chemical compound C1=C(OC)C(OC)=CC=C1CC(NC=O)C1=CC=C(C)C=C1 GFBZBTGJEJNXJN-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960003279 thiopental Drugs 0.000 description 1
- 229940125725 tranquilizer Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
Vynález se týká 2,3,10,ll-tetramethoxy-6-(4-tolyl)berbinu vzorce IThe invention relates to 2,3,10,11-tetramethoxy-6- (4-tolyl) berbine of formula I
a jeho hydrochloridu.and its hydrochloride.
Látka vzorce I a její hydrochlorid projevují v biologických testech farmakodynamickou a antimikrobiální účinnost, takže mohou nalézt použití v therapii. Hydrochlorid látky I (který byl farmakologlcky testován jako krystalický monohydrátj je látkou téměř netoxickou. Její střední smrtná dávka při orálním podání myším je vyšší než 2,5 g/kg. V testech na zvířatech projevuje látka vlastnosti trankvilizéru. Projevuje se zejména potenciací thiopentalového spánku u myší, kdy orální dávky 100 až 300 mg/kg prodlužují trvání hypnotického účinku thiopentalu na dvojnásobek kontrolní hodnoty. V tomtéž smyslu je nutné interpretovat též význačný hypothermický účinek u krys: orální dávky látky 110 až 100 mg/kg způsobují signifikantní pokles tělesné teploty měřené rektálně. Antimikrobiální účinek látky I je orientován zejména na kvasinky a nižší houby, zčásti pathogenní. Tak koncentrace 100 (Ug/ml látky I inhibují růst organismů Saccharomyces pasterianus, Candida albicans a Aspergillus niger. Trichophyton mentagrophytes je inhibován již koncentrací 50 ^g/ml. Látka I a její hydrochlorid jsou tedy trankvilizéry se specifickým antimikrobiálním působením.The compound of formula I and its hydrochloride exhibit pharmacodynamic and antimicrobial activity in biological assays, so that they can find use in therapy. The hydrochloride of Compound I (which has been pharmacologically tested as crystalline monohydrate) is almost non-toxic. Its median lethal dose to mice is greater than 2.5 g / kg. In animal tests, the substance exhibits tranquilizer properties. mice, where oral doses of 100-300 mg / kg prolong the duration of the hypnotic effect of thiopental to twice the control value, and a significant hypothermic effect in rats must also be interpreted in the same sense: oral doses of 110-100 mg / kg cause The antimicrobial effect of Compound I is mainly directed towards yeasts and inferior fungi, partly pathogenic, thus concentrations of 100 (Ug / ml of Compound I inhibit the growth of Saccharomyces pasterianus, Candida albicans and Aspergillus niger). L Units I and its hydrochloride are thus tranquilizers a specific antimicrobial treatment.
Látka I je syntheticky přístupná Pictet-Spenglerovou reakcí z 1,2,3,4-tetrahydroisochinolinového derivátu vzorce II.Compound I is synthetically accessible by the Pictet-Spengler reaction of the 1,2,3,4-tetrahydroisoquinoline derivative of formula II.
Uvedená reakce spočívá v působení vodného formaldehydu v methanolu a v zahřátí reakční směsi s kyselinou solnou, při čemž vzniká přímo hydrochlorid látky I. Hydrochlorid je dobře krystalující látka, která rozkladem vodným amoniakem poskytuje basi vzorce I, rovněž krystalickou. Výchozí látka vzorce II nebyla v literatuře zatím popsána a její příprava je popisována v dále uvedeném popisu synthesy. Látka I, její hydrochlorid i řada meziproduktů jsou látky nové, jejichž identita byla zajištěna jednak analyticky, jednak pomocí spektrálních metod (UF, IČ a *H NMR spektra). Látka vzorce I vykazuje v molekule přítomnost dvou center chirality a v souladu s tím je schopna existovat ve dvou racemických formách. Krystalisací surového produktu se získává poměrně snadno homogenní substance, kterou je nutno považovat za jeden individuální racemát. Protože teplota tání analytického vzorku není příliš vzdálena od teploty tání surové látky, je nutno mít zato, že reakce probíhá značně stereospecificky a že jeden z racemátů je převažujícím produktem. V dalším je popsána synthesa látky I a jejího hydrochlorldu.The reaction consists in treating aqueous formaldehyde in methanol and heating the reaction mixture with hydrochloric acid to give the hydrochloride of compound I directly. The hydrochloride is a well-crystallizing substance which, by decomposition with aqueous ammonia, also gives a base of formula I also crystalline. The starting material of formula (II) has not yet been described in the literature and its preparation is described in the following description of the synthesis. Substance I, its hydrochloride and a number of intermediates are novel substances whose identity has been established both analytically and by spectral methods (UF, IR and 1 H NMR spectra). The compound of formula I exhibits two chiral centers in the molecule and is accordingly able to exist in two racemic forms. Crystallization of the crude product yields a relatively homogeneous substance which is to be regarded as one individual racemate. Since the melting point of the analytical sample is not too far from the melting point of the crude, it is to be understood that the reaction proceeds considerably stereospecifically and that one of the racemates is the predominant product. The synthesis of compound I and its hydrochloride is described below.
Hydrochlorid 6,7-dimethoxy-l- (3,4-dimethoxybenzyl) -3- (4-toly 1) -1,2,3,4-tetrahydroisochinolinu (47 g) se rozloží 500 ml 20% roztoku hydroxidu sodného a uvolněná base se isoluje extrakcí chloroformem. Získá se jako čirý olej ve výtěžku 45 g. Celé toto kvantum se rozpustí ve 250 ml methanolu, přidá se 50 ml 36% vodného formaldehydu a směs se ponechá v klidu při teplotě místnosti po dobu 8 dnů. Potom se přidá 260 ml 5M-HC1 a získaný roztok se vaří 50 min pod zpětným chladičem. Po stání dalších 14 dnů při teplotě místnosti se vyloučený monohydrát hydrochloridu 2,3,10,ll-tetramethoxy-6- (4-tolyl) berbinu (I) odsaje, promyje směsí methanolu a etheru a vysuší. Získá se 40 g (83 %) surového produktu tajícího při 170 až 174 °C. Krystalisací z ethanolu se získá homogenní produkt (jeden individuální racemát) tající za rozkladu při 176 až 177 °C. Rozkladem tohoto hydrochloridu vodným amoniakem a extrakcí etherem se získá volná krystalická base vzorce I, která v čistém stavu taje při 87 až 91 °C.6,7-Dimethoxy-1- (3,4-dimethoxybenzyl) -3- (4-tolyl) -1,2,3,4-tetrahydroisoquinoline hydrochloride (47 g) was quenched with 500 mL of 20% sodium hydroxide solution and liberated the base was isolated by extraction with chloroform. It is obtained as a clear oil in a yield of 45 g. This whole quantity is dissolved in 250 ml of methanol, 50 ml of 36% aqueous formaldehyde is added and the mixture is left at room temperature for 8 days. Then, 260 ml of 5M-HCl was added and the solution was refluxed for 50 min. After standing for an additional 14 days at room temperature, the precipitated 2,3,10,11-tetramethoxy-6- (4-tolyl) berbine hydrochloride monohydrate (I) is filtered off with suction, washed with a mixture of methanol and ether and dried. 40 g (83%) of crude product melting at 170-174 ° C are obtained. Crystallization from ethanol gave a homogeneous product (one individual racemate) melting at 176-177 ° C with decomposition. Decomposition of the hydrochloride with aqueous ammonia and extraction with ether yields the free crystalline base of formula I, which melts in a pure state at 87-91 ° C.
Výchozí hydrochlorid 6,7-dimethoxy-l-(3,4-dimethoxybenzyl) -3- (4-tolyl) -1,2,3,4-tetrahydroisochinolinu (II) zatím nebyl v literatuře popsán. Lze je] získat dále uvedenou řetězovou synthesou, která vychází z reakce homoveratroylchloridu (Haworth R. D. a spol., ]. Chem. Soc. 125, 1686, 1924) s toluenem.The starting 6,7-dimethoxy-1- (3,4-dimethoxybenzyl) -3- (4-tolyl) -1,2,3,4-tetrahydroisoquinoline hydrochloride (II) has not been described in the literature. They can be obtained by the following chain synthesis starting from the reaction of homoveratroyl chloride (Haworth R. D. et al., Chem. Soc. 125, 1686, 1924) with toluene.
K míchané suspenzi 450 g bezvodého chloridu hlinitého v 700 ml toluenu se během 3 h přikape při 15 °C roztok 430 g homoveratroylchloridu v 800 ml toluenu, směs se míchá 6,5 h při 15 °C, ponechá se při teplotě místnosti přes noc a potom se rozloží vlitím do směsi 5 1 5M-HC1 a 5 kg ledu. Směs se míchá 45 min. a po roztáni ledu se extrahuje chloroformem. Extrakt se promyje vodou,To a stirred suspension of 450 g of anhydrous aluminum chloride in 700 ml of toluene, a solution of 430 g of homoveratroyl chloride in 800 ml of toluene was added dropwise over 3 hours at 15 ° C, stirred for 6.5 hours at 15 ° C, left at room temperature overnight. then decompose by pouring into a mixture of 5 L of 5M-HCl and 5 kg of ice. The mixture was stirred for 45 min. and extracted with chloroform after melting the ice. The extract is washed with water,
5% roztokem hydroxidu sodného a vodou, vysuší se síranem hořečnatým a odpaří za sníženého tlaku. Získá se 387 g (72 %) surového krystalického 2-(3,4-dimethoxyfenyl)-4'-methylacetofenonu tajícího při 98 až 102 °C (jihnutí od 94 °C). Tato látka je dostatečně čistá pro další zpracování. Pro charakterisaci lze krystalisací vzorku z methanolu získat zcela čistou látku tající při 104 až5% sodium hydroxide solution and water, dried over magnesium sulfate and evaporated under reduced pressure. 387 g (72%) of crude crystalline 2- (3,4-dimethoxyphenyl) -4'-methylacetophenone melting at 98-102 ° C (south of 94 ° C) is obtained. This material is sufficiently pure for further processing. For characterization, a completely pure material, m.p.
105,5 °C. Rovněž pro charakterisaci lze připravit reakcí tohoto ketonu s hydrochloridem hydroxylaminu ve vroucím ethanolu za přítomnosti hydrogenuhličitanu sodného vzorek oximu, který krystaluje z vodného methanolu a taje při 113 až 115,5 °C.105.5 ° C. Also for characterization, a sample of the oxime can be prepared by reacting this ketone with hydroxylamine hydrochloride in boiling ethanol in the presence of sodium bicarbonate, which crystallizes from aqueous methanol and melts at 113-115.5 ° C.
Směs 270 g předešlého ketonu, 680 g formamidu a 140 g 98% kyseliny mravenčí se zvolna zahřívá až do dosažení teploty 170 až 180 °C, při které se směs udržuje po dobu ’ 12 h. Po ochlazení se směs zředí 3 1 vody při 60 °C, míchá se 1 h, ochladí na 30 °C a vyloučený pevný N-/2-(3,4-dimethoxyfenyl)-l-(4-tolyl)ethyl/formamid se odsaje, promyje vodou a vysuší. Získá se v téměř teoretickém výtěžku 297 g a taje při 128 až 131 °C. Pro další práci je takto dostatečně čistý. Pro charakterisaci lze vzorek vyčistit krystalisací z vodného methanolu; taje potom při 134 až 135 °C.A mixture of 270 g of the previous ketone, 680 g of formamide and 140 g of 98% formic acid was slowly heated until a temperature of 170-180 ° C was reached, maintaining the mixture for 12 h. The mixture was cooled to 30 ° C and the precipitated solid N- [2- (3,4-dimethoxyphenyl) -1- (4-tolyl) ethyl] formamide was filtered off with suction, washed with water and dried. It is obtained in an almost theoretical yield of 297 g and melts at 128-131 ° C. It is sufficiently clean for further work. For characterization, the sample can be purified by crystallization from aqueous methanol; it melts at 134-135 ° C.
Směs 297 g předešlého amidu, 350 ml ethanolu a 310 g 85% hydroxidu draselného se míchá a vaří 3 h pod zpětným chladičem v lázni o teplotě 120 °C. Zředí se potom 1,5 1 vody a base se extrahuje etherem. Extrakt se vysuší uhličitanem draselným a odpaří. Získá se 252 g (93%) olejovitého 2-(3,4-dimethoxyf eny 1 )-1-( 4-tolyl) ethylaminu, který se rozpustí v 500 ml ethanolu, přidá se slabý přebytek roztoku chlorovodíku v etheru a ještě 1 1 etheru. Stáním a chlazením se vyloučí 240 g (78%) krystalického hydrochloridu, který taje při 228 až 229,5 °C. je prakticky čistý a vhodný k dalšímu zpracování.A mixture of 297 g of the previous amide, 350 ml of ethanol and 310 g of 85% potassium hydroxide was stirred and refluxed in a 120 ° C bath for 3 h. It is then diluted with 1.5 L of water and the base is extracted with ether. The extract was dried over potassium carbonate and evaporated. 252 g (93%) of oily 2- (3,4-dimethoxyphenyl) -1- (4-tolyl) ethylamine are obtained, which is dissolved in 500 ml of ethanol, a slight excess of a solution of hydrogen chloride in ether is added, and a further 1 l of of ether. On standing and cooling 240 g (78%) of crystalline hydrochloride precipitated, melting at 228-229.5 ° C. is practically clean and suitable for further processing.
Ke směsi 62. g předešlého hydrochloridu a 300 ml pyridinu se přidá roztok 58 g homoveratroylchloridu ve 100 ml toluenu a směs se míchá 7,5 h při 60 až 70 °C. Po ochlazení se nalije do 3 1 ledové vody, vyloučený pevný produkt se odsaje, promyje vodou, vysuší a překrystaluje z 1 1 toluenu. Získá se 73 g (82 %) N-/2- (3,4-dimethoxyfenyl )-1-( 4-to-lyl) ethyl/-3,4-dimethoxyfenylacetamidu, který při zahřívání roztaje při 152 až 155 °C, potom opět ztuhne a taje znovu při 163 až 164 °C.To a mixture of 62 g of the preceding hydrochloride and 300 ml of pyridine was added a solution of 58 g of homoveratroyl chloride in 100 ml of toluene, and the mixture was stirred at 60-70 ° C for 7.5 h. After cooling, it is poured into 3 l of ice water, the precipitated solid product is filtered off with suction, washed with water, dried and recrystallized from 1 l of toluene. 73 g (82%) of N- [2- (3,4-dimethoxyphenyl) -1- (4-tolyl) ethyl] -3,4-dimethoxyphenylacetamide are obtained, which melts at 152-155 [deg.] C. when heated, then it solidifies again and melts again at 163-164 ° C.
Směs 90 g předešlého amidu, 400 ml toluenu, 300 ml oxychloridu fosforečného a 30 g oxidu fosforečného se míchá a vaří 5 h pod zpětným chladičem. Potom se odpaří ža sníženého tlaku. Zbytek se rozpustí ve 3 1 ethanolu, roztok se zneutralisuje 350 ml 5M-NaOH a za míchání se během 30 min. zvolna přidá 30 g borohydridu sodného. Směs se vaří 3 h pod zpětným chladičem, odpaří se za sníženého tlaku, zbytek se zalkalisuje 5M-NaOH a extrahuje se benzenem. Extrakt se protřepe s přebytečnou 1M-HC1 a vyloučený hydrochlorid 6,7-dimethoxy-l-(3,4-dimethoxybenzyl) -3- (4-tolyl J -1,2,3,4-tetrahydroisochinolinu (II) se isoluje odsátím, promytím směsí ethanolu a etheru a vysušením.A mixture of the previous amide (90 g), toluene (400 ml), phosphorus oxychloride (300 ml) and phosphorus pentoxide (30 g) was stirred and refluxed for 5 hours. It is then evaporated under reduced pressure. The residue was dissolved in 3 L of ethanol, neutralized with 350 mL of 5M-NaOH and stirred with stirring for 30 min. slowly add 30 g of sodium borohydride. The mixture was refluxed for 3 h, evaporated under reduced pressure, basified with 5M-NaOH and extracted with benzene. The extract is shaken with excess 1M-HCl and the precipitated 6,7-dimethoxy-1- (3,4-dimethoxybenzyl) -3- (4-tolyl) -1,2,3,4-tetrahydroisoquinoline hydrochloride (II) is isolated by suction , washing with a mixture of ethanol and ether and drying.
Získá se 61 g (65 %} látky s t. t. 217 až61 g (65%) of m.p.
218,5 °C za rozkladu, která je vhodná jako surovina pro poslední stupeň synthesy. Pro charakterisaci se rekrystalisací z 80% ethanolu získá čistá látka tající při 220 až 221 °C za rozkladu.218.5 ° C with decomposition, which is suitable as a raw material for the last stage of synthesis. For characterization, recrystallization from 80% ethanol gave a pure material melting at 220-221 ° C with decomposition.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS782682A CS225599B1 (en) | 1982-11-03 | 1982-11-03 | 2,3,10,11-tetramethoxy-6-/4-tolyl/berbine and its hydrochloride |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS782682A CS225599B1 (en) | 1982-11-03 | 1982-11-03 | 2,3,10,11-tetramethoxy-6-/4-tolyl/berbine and its hydrochloride |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS225599B1 true CS225599B1 (en) | 1984-02-13 |
Family
ID=5428102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS782682A CS225599B1 (en) | 1982-11-03 | 1982-11-03 | 2,3,10,11-tetramethoxy-6-/4-tolyl/berbine and its hydrochloride |
Country Status (1)
| Country | Link |
|---|---|
| CS (1) | CS225599B1 (en) |
-
1982
- 1982-11-03 CS CS782682A patent/CS225599B1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jones | Studies on imidazole compounds. I. A synthesis of imidazoles with functional groups in the 2-position | |
| US4110337A (en) | Triazolobenzodiazepines | |
| Leonard et al. | Characterization of Nx, Ny‐Disubstituted adenines by ultraviolet absorption spectra | |
| SE461468B (en) | IMIDAZO 4,5-B QUINOLIN-2-ON DERIVATIVES, PROCEDURES FOR THE PREPARATION OF THIS, INTERMEDIATES AND A PHARMACEUTICAL PREPARATION | |
| RS49626B (en) | A NEW PROCEDURE FOR OBTAINING PHARMACOLOGICAL ACTIVE SUBSTANCE | |
| AU702587B2 (en) | New heterocyclic spiro compounds, process for the preparation thereof,and pharmaceutical compositions containing them | |
| US4118561A (en) | 7-(Substituted)-7H-pyrrolo[3,2-f]quinazoline-1,3-diamines | |
| SU1195903A3 (en) | Method of producing 1-phenyl-2-aminocarbonylindole compounds or their salts of acid connection | |
| SU1169538A3 (en) | Method of obtaining tricyclic compounds | |
| Bridson et al. | The reaction of 5‐aminoimidazole‐4‐carbohydrazides with orthoesters | |
| CS225599B1 (en) | 2,3,10,11-tetramethoxy-6-/4-tolyl/berbine and its hydrochloride | |
| HU192836B (en) | Process for producing substituted azabicyclo-alkane derivatives and pharmaceutical compositions containing them | |
| US3202669A (en) | 6-methoxy-1-(3, 4, 5-trimethoxy phenyl)-9h-pyrido [3, 4-b] indole and its acid addition salts | |
| NO792275L (en) | PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE PYRAZOLO-PYRIDINE DERIVATIVES | |
| DK169970B1 (en) | Intermediates for use in the preparation of pyrimido [4,5-g] quinoline derivatives or salts thereof | |
| PL162513B1 (en) | Method for the production of new derivatives and midazole PL PL PL PL PL | |
| US2918472A (en) | 5-methyl, 4-amino-3-isoxazolidone | |
| CS225598B1 (en) | Tri-substituted 3-/4-tolyl/-1,2,3,4-tetrahydroisoquinolines and their salts | |
| Bianchi et al. | 5‐Oxo‐1H‐4, 5‐dihydro‐1, 2, 4‐benzotriazepines. Chemical behavior towards alkylating, acidic and alkaline agents | |
| King et al. | 297. The synthesis of benziminazoles from ortho-phenylenediamines and imino-ethers | |
| EP0161235A2 (en) | Thienopyridinone derivatives, process for their preparation and pharmaceutical compositions containing them | |
| PL111060B1 (en) | Preparation of novel isoindoline derivatives | |
| FR2475550A1 (en) | 4- (2- (1H-IMIDAZOL-1-YLMETHYL) -1,3-DIOXOLAN-4-YL) -METHOXYPYRAZOLO (3,4-B) PYRIDINES WITH ANTI-BACTERIAL ACTION, AND PROCESS FOR THE PREPARATION THEREOF | |
| Moiseev et al. | Investigations on 2, 3′-biquinolines. 18. New convenient one-pot synthesis of 1′-alkyl-1′, 4′-dihydro-2, 3′-biquinolyl-4′-thiones and their conversion into 1′-alkyl-1′, 4′-dihydro-2, 3′-biquinolyl-4′-ones | |
| CS217947B1 (en) | 2-Benzylcyclopentylamine, its methyl derivatives and salts |